Weiss Multi Strategy Advisers LLC Kal Vista Pharmaceuticals, Inc. Transaction History

Weiss Multi Strategy Advisers LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 16, 2020	SELL	$9.83 - $13.99 $196,079 - $279,058	-19,947 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$6.75 - $12.89 $4,630 - $8,842	686 Added 3.56%	19,947 $241,000
Q1 2020 May 15, 2020	SELL	$5.8 - $18.56 $4,286 - $13,715	-739 Reduced 3.7%	19,261 $147,000
Q4 2019 Feb 14, 2020	SELL	$10.31 - $17.81 $350,540 - $605,540	-34,000 Reduced 62.96%	20,000 $356,000
Q1 2019 May 15, 2019	BUY	$16.51 - $31.1 $214,630 - $404,300	13,000 Added 31.71%	54,000 $1.55 Million
Q4 2018 Feb 14, 2019	BUY	$16.21 - $24.06 $16,210 - $24,060	1,000 Added 2.5%	41,000 $810,000
Q3 2018 Nov 14, 2018	BUY	$8.0 - $22.11 $320,000 - $884,400	40,000 New	40,000 $884,000

135

52M

551K

98K

Ticker KALV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 24,602,000
Market Cap $240M
Description
KalVista Pharmaceuticals, Inc., a clinical stage pharmaceutical company, discovers, develops, and commercializes small molecule protease inhibitors for diseases with unmet needs. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema (HAE) and diabetic macular edema (DME); and oral p...

Get notified when there are updates to the investment portfolio of Weiss Multi Strategy Advisers LLC, based on Form 13F filings with the SEC.

Stay updated on Weiss Multi Strategy Advisers LLC with notifications on news.